Synthesis of Platelet Activating Factor by Ocular Tissue From Inflamed Eyes

James (Jim) Rosenbaum, Richard S. Boney, John R. Samples, Frank H. Valone

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Platelet activating factors (PAFs) are a family of ether lipids with properties that suggest a major role in inflammation. We have previously implicated PAFs in ocular inflammation based on the inhibition of several rabbit models of iritis with a specific PAF receptor antagonist. We have tested ocular tissues for the ability to synthesize PAF. Iris, ciliary body, cornea, and/or retina were carefully dissected from New Zealand white rabbits, and tissue from four eyes was pooled. Tissues were stimulated with calcium ionophore (10 μmol/L), and supernatants were extracted with chloroformmethanol. Platelet-aggregating activity was found in the chloroform phase in 2 of 9, 1 of 8, 0 of 9, and 3 of 9 studies involving iris, retina, ciliary body, or cornea, respectively. Twenty-four hours after the intravitreal injection of 125 ng of endotoxin, aggregating activity was consistently detectable from supernatants of stimulated iris and ciliary body, occasionally present from stimulated retina but not detectable from cornea. The shape of the aggregation curve resembled that produced by 0.5 to 2.0 ng of authentic PAF. Moreover, the aggregation could be completely inhibited by a PAF receptor antagonist and the aggregating activity chromatographed identically on high-performance liquid chromatography to a PAF standard. These studies indicate that PAF-like activity could be detected from several ocular tissues subsequent to inflammation. Iris, ciliary body, retina, vascular endothelium, and/or leukocytes could each contribute to the presence of this inflammatory mediator.

Original languageEnglish (US)
Pages (from-to)410-413
Number of pages4
JournalArchives of Ophthalmology
Volume109
Issue number3
DOIs
StatePublished - 1991

Fingerprint

Platelet Activating Factor
Ciliary Body
Iris
Retina
Cornea
Inflammation
Iritis
Rabbits
Intravitreal Injections
Calcium Ionophores
Vascular Endothelium
Chloroform
Endotoxins
Ether
Leukocytes
Blood Platelets
High Pressure Liquid Chromatography
Lipids

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Synthesis of Platelet Activating Factor by Ocular Tissue From Inflamed Eyes. / Rosenbaum, James (Jim); Boney, Richard S.; Samples, John R.; Valone, Frank H.

In: Archives of Ophthalmology, Vol. 109, No. 3, 1991, p. 410-413.

Research output: Contribution to journalArticle

Rosenbaum, James (Jim) ; Boney, Richard S. ; Samples, John R. ; Valone, Frank H. / Synthesis of Platelet Activating Factor by Ocular Tissue From Inflamed Eyes. In: Archives of Ophthalmology. 1991 ; Vol. 109, No. 3. pp. 410-413.
@article{e68f0f1483de479d9721ed58159e2922,
title = "Synthesis of Platelet Activating Factor by Ocular Tissue From Inflamed Eyes",
abstract = "Platelet activating factors (PAFs) are a family of ether lipids with properties that suggest a major role in inflammation. We have previously implicated PAFs in ocular inflammation based on the inhibition of several rabbit models of iritis with a specific PAF receptor antagonist. We have tested ocular tissues for the ability to synthesize PAF. Iris, ciliary body, cornea, and/or retina were carefully dissected from New Zealand white rabbits, and tissue from four eyes was pooled. Tissues were stimulated with calcium ionophore (10 μmol/L), and supernatants were extracted with chloroformmethanol. Platelet-aggregating activity was found in the chloroform phase in 2 of 9, 1 of 8, 0 of 9, and 3 of 9 studies involving iris, retina, ciliary body, or cornea, respectively. Twenty-four hours after the intravitreal injection of 125 ng of endotoxin, aggregating activity was consistently detectable from supernatants of stimulated iris and ciliary body, occasionally present from stimulated retina but not detectable from cornea. The shape of the aggregation curve resembled that produced by 0.5 to 2.0 ng of authentic PAF. Moreover, the aggregation could be completely inhibited by a PAF receptor antagonist and the aggregating activity chromatographed identically on high-performance liquid chromatography to a PAF standard. These studies indicate that PAF-like activity could be detected from several ocular tissues subsequent to inflammation. Iris, ciliary body, retina, vascular endothelium, and/or leukocytes could each contribute to the presence of this inflammatory mediator.",
author = "Rosenbaum, {James (Jim)} and Boney, {Richard S.} and Samples, {John R.} and Valone, {Frank H.}",
year = "1991",
doi = "10.1001/archopht.1991.01080030112049",
language = "English (US)",
volume = "109",
pages = "410--413",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Synthesis of Platelet Activating Factor by Ocular Tissue From Inflamed Eyes

AU - Rosenbaum, James (Jim)

AU - Boney, Richard S.

AU - Samples, John R.

AU - Valone, Frank H.

PY - 1991

Y1 - 1991

N2 - Platelet activating factors (PAFs) are a family of ether lipids with properties that suggest a major role in inflammation. We have previously implicated PAFs in ocular inflammation based on the inhibition of several rabbit models of iritis with a specific PAF receptor antagonist. We have tested ocular tissues for the ability to synthesize PAF. Iris, ciliary body, cornea, and/or retina were carefully dissected from New Zealand white rabbits, and tissue from four eyes was pooled. Tissues were stimulated with calcium ionophore (10 μmol/L), and supernatants were extracted with chloroformmethanol. Platelet-aggregating activity was found in the chloroform phase in 2 of 9, 1 of 8, 0 of 9, and 3 of 9 studies involving iris, retina, ciliary body, or cornea, respectively. Twenty-four hours after the intravitreal injection of 125 ng of endotoxin, aggregating activity was consistently detectable from supernatants of stimulated iris and ciliary body, occasionally present from stimulated retina but not detectable from cornea. The shape of the aggregation curve resembled that produced by 0.5 to 2.0 ng of authentic PAF. Moreover, the aggregation could be completely inhibited by a PAF receptor antagonist and the aggregating activity chromatographed identically on high-performance liquid chromatography to a PAF standard. These studies indicate that PAF-like activity could be detected from several ocular tissues subsequent to inflammation. Iris, ciliary body, retina, vascular endothelium, and/or leukocytes could each contribute to the presence of this inflammatory mediator.

AB - Platelet activating factors (PAFs) are a family of ether lipids with properties that suggest a major role in inflammation. We have previously implicated PAFs in ocular inflammation based on the inhibition of several rabbit models of iritis with a specific PAF receptor antagonist. We have tested ocular tissues for the ability to synthesize PAF. Iris, ciliary body, cornea, and/or retina were carefully dissected from New Zealand white rabbits, and tissue from four eyes was pooled. Tissues were stimulated with calcium ionophore (10 μmol/L), and supernatants were extracted with chloroformmethanol. Platelet-aggregating activity was found in the chloroform phase in 2 of 9, 1 of 8, 0 of 9, and 3 of 9 studies involving iris, retina, ciliary body, or cornea, respectively. Twenty-four hours after the intravitreal injection of 125 ng of endotoxin, aggregating activity was consistently detectable from supernatants of stimulated iris and ciliary body, occasionally present from stimulated retina but not detectable from cornea. The shape of the aggregation curve resembled that produced by 0.5 to 2.0 ng of authentic PAF. Moreover, the aggregation could be completely inhibited by a PAF receptor antagonist and the aggregating activity chromatographed identically on high-performance liquid chromatography to a PAF standard. These studies indicate that PAF-like activity could be detected from several ocular tissues subsequent to inflammation. Iris, ciliary body, retina, vascular endothelium, and/or leukocytes could each contribute to the presence of this inflammatory mediator.

UR - http://www.scopus.com/inward/record.url?scp=0026035895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026035895&partnerID=8YFLogxK

U2 - 10.1001/archopht.1991.01080030112049

DO - 10.1001/archopht.1991.01080030112049

M3 - Article

C2 - 2003804

AN - SCOPUS:0026035895

VL - 109

SP - 410

EP - 413

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 3

ER -